Details: 3fdc(p) (h50, r75, z150) [dstb-ip(p)(isoniazid ip 50 mg(h) + rifampicin ip 75 mg(r) + tab pyrazinamide ip 150mg(z))each fdc tablet contains:- isoniazid ip 50 mg(h) + rifampicin ip 75 mg(r) + tab pyrazinamide ip 150mg(z) & specification as per annexure-a of the referred tender no. e-630176/12371, dated 18.03.2025. 2fdc (p) (h50 & r75) [dstb-cp(p)each fdc tablet contains:-isoniazid ip 50 mg (h) + rifampicin ip 75 mg (r ) & specification as per annexure-b, of the referred tender no. e-630176/12371, dated 18.03.2025. cycloserine each capsule contain:-cycloserine 250 mg & specification as per annexure-d, of the referred tender no. e-630176/12371, dated 18.03.2025. ethambutol each tablet contain:-ethambutol hydrochloride 100 mg & specification as per annexure-e, of the referred tender no. e-630176/12371, dated 18.03.2025. ethambutol each tablet contain:-ethambutol hydrochloride 400mg & specification as per annexure-f, of the referred tenderno. e-630176/12371, dated 18
Sector: Medical and Health